Orchestra BioMed Holdings, Inc. (OBIO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2021: -$272.4K2022: -$29.29M2023: -$46.13M2024: -$50.56M2025: -$48.96M-$48.96M
2021Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$48.96M+3.2%
2024-$50.56M-9.6%
2023-$46.13M-57.5%
2022-$29.29M-10653.7%
2021-$272.4K